Agilent Technologies Stock Forecast, Price & News

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 2 hold ratings and 20 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Agilent Technologies stock.
View analyst ratings for Agilent Technologies or view top-rated stocks.

Wall Street analysts have given Agilent Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Agilent Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Agilent Technologies saw a increase in short interest in August. As of August 13th, there was short interest totaling 3,890,000 shares, an increase of 16.5% from the July 29th total of 3,340,000 shares. Based on an average daily volume of 1,800,000 shares, the short-interest ratio is presently 2.2 days. Approximately 1.3% of the shares of the stock are sold short.
View Agilent Technologies' Short Interest.

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Monday, November 22nd 2021.
View our earnings forecast for Agilent Technologies.

Agilent Technologies, Inc. (NYSE:A) released its quarterly earnings data on Monday, August, 16th. The medical research company reported $1.10 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.99 by $0.11. The medical research company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.54 billion. Agilent Technologies had a trailing twelve-month return on equity of 26.12% and a net margin of 16.12%. The business's revenue for the quarter was up 25.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.78 earnings per share.
View Agilent Technologies' earnings history.

Agilent Technologies' stock was trading at $68.84 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, A stock has increased by 152.7% and is now trading at $173.94.
View which stocks have been most impacted by COVID-19.

Agilent Technologies declared a quarterly dividend on Wednesday, May 19th. Investors of record on Tuesday, July 6th will be given a dividend of $0.194 per share on Wednesday, July 28th. This represents a $0.78 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Friday, July 2nd.
View Agilent Technologies' dividend history.

Agilent Technologies pays an annual dividend of $0.78 per share and currently has a dividend yield of 0.45%. The dividend payout ratio of Agilent Technologies is 23.78%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 16.49% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.
View Agilent Technologies' dividend history.

Agilent Technologies announced that its Board of Directors has authorized a stock repurchase program on Tuesday, February 16th 2021, which authorizes the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 5% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board of directors believes its shares are undervalued.

Agilent Technologies updated its FY 2021 earnings guidance on Tuesday, September, 14th. The company provided EPS guidance of $4.280-$4.310 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.140. The company issued revenue guidance of $6.29 billion-$6.32 billion, compared to the consensus revenue estimate of $6.22 billion.

22 brokers have issued 1-year price targets for Agilent Technologies' stock. Their forecasts range from $30.70 to $200.00. On average, they expect Agilent Technologies' share price to reach $137.04 in the next year. This suggests that the stock has a possible downside of 21.2%.
View analysts' price targets for Agilent Technologies or view top-rated stocks among Wall Street analysts.

452 employees have rated Agilent Technologies CEO Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among Agilent Technologies' employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), PerkinElmer (PKI), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of A's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), The Boeing (BA) and Skyworks Solutions (SWKS).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.45%), Vanguard Group Inc. (7.87%), Price T Rowe Associates Inc. MD (7.78%), State Street Corp (4.26%), Pershing Square Capital Management L.P. (3.85%) and Invesco Ltd. (1.95%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., Teacher Retirement System of Texas, Marshall Wace North America L.P., Ceredex Value Advisors LLC, CCLA Investment Management Ltd, Primecap Management Co. CA, Pershing Square Capital Management L.P., and Jupiter Asset Management Ltd.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, and Samraat S Raha.
View insider buying and selling activity for Agilent Technologies or view top insider-selling stocks.

A stock was purchased by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Amundi, JPMorgan Chase & Co., First Trust Advisors LP, Macquarie Group Ltd., Massachusetts Financial Services Co. MA, BlackRock Inc., and Geode Capital Management LLC.
View insider buying and selling activity for Agilent Technologies or or view top insider-buying stocks.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of A stock can currently be purchased for approximately $173.94.

Agilent Technologies has a market capitalization of $52.66 billion and generates $5.34 billion in revenue each year. The medical research company earns $719 million in net income (profit) each year or $3.28 on an earnings per share basis.

Agilent Technologies employs 16,400 workers across the globe.

The following companies are subsidiares of Agilent Technologies: ACEA BIO, AT Singapore (Global) Pte Ltd., ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Rhone AG, Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako ApS, Dako Denmark, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.

Agilent Technologies was founded in 1999.

The official website for Agilent Technologies is www.agilent.com.

Agilent Technologies is headquartered at 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at (800) 227-9770 or via email at [email protected].